Sulforaphane has an additive anticancer effect to FOLFOX in highly metastatic human colon carcinoma cells.
Sign Up to like & getrecommendations! Published in 2022 at "Oncology reports"
DOI: 10.3892/or.2022.8420
Abstract: Colorectal cancer (CRC) is one of the most common malignancies worldwide. Patients with CRC may need chemotherapy (CTx) in a neoadjuvant, adjuvant or palliative setting through the course of the disease. Unfortunately, its effect is… read more here.
Keywords: metastatic human; effect; human colon; crc ... See more keywords